INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Capital Work in Progress History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹0.50 Cr | - | ₹3.78 Cr | ₹1.37 Cr | ₹2.33 Cr |
What is the latest Capital Work in Progress ratio of INDO US BIOTECH ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹0.50 Cr |
| Mar2025 | - |
| Mar2024 | ₹3.78 Cr |
| Mar2023 | ₹1.37 Cr |
| Mar2022 | ₹2.33 Cr |
How is Capital Work in Progress of INDO US BIOTECH Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.50 Cr | 0 | |
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹3.78 Cr | 176.37 | |
| Mar2023 | ₹1.37 Cr | -41.20 | |
| Mar2022 | ₹2.33 Cr | - | |
Compare Capital Work in Progress of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹144.7 Cr | NA | -10% | -44.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,763.3 Cr | 2.9% | 3.9% | -31.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,428.9 Cr | 7.6% | 4.3% | 14.9% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,518.6 Cr | 2.9% | 17.1% | 46.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,005.9 Cr | 6.1% | 6.5% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹560.6 Cr | 5% | 9.4% | 1.8% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | NA |
-10% |
-44.6% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses